Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
Public ClinicalTrials.gov record NCT00319969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2 Trial Comparing Amrubicin Versus Topotecan as Second-Line Treatment in Patients With Extensive Small Cell Lung Cancer Sensitive to First-Line Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the objective tumor response rate of amrubicin or standard topotecan therapy when administered as second-line therapy to ED-SCLC patients who have chemotherapy sensitive recurrent or progressive.
Study identification
- NCT ID
- NCT00319969
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 76 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2006 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Jan 2009 (Actual)
- Last update posted
- Sep 30, 2009
2006 – 2009
United States locations
- U.S. sites
- 47
- U.S. states
- 21
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Hematology & Oncology | Birmingham | Alabama | 35205 | — |
| Hematology Oncology Associates | Phoenix | Arizona | 85012 | — |
| Alta Bates Medical Center - Comprehensive Cancer Center | Berkeley | California | 94704 | — |
| Moores UCSD Cancer Center | La Jolla | California | 92093 | — |
| Rocky Mountain Cancer Center - Denver | Denver | Colorado | 80218 | — |
| Rocky Mountain Cancer Center - Sky Ridge | Lone Tree | Colorado | 80124 | — |
| Ocala Oncology Center | Ocala | Florida | 34474 | — |
| Cancer Centers of Florida, PA | Ocoee | Florida | 34761 | — |
| John B. Amos Cancer Center | Columbus | Georgia | 31904 | — |
| Cancer Care & Hematology Specialists of Chicago | Niles | Illinois | 60714 | — |
| Oncology & Hematology of Central Illinois | Peoria | Illinois | 61602 | — |
| Blessing Cancer Center | Quincy | Illinois | 62301 | — |
| Central Indiana Cancer Centers | Indianapolis | Indiana | 46227 | — |
| Hope Center | Terre Haute | Indiana | 47802 | — |
| Norton Healthcare - Louisville Oncology | Louisville | Kentucky | 40202 | — |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | — |
| Johns Hopkins Hospital - The Bunting Blaustein Cancer Research Building | Baltimore | Maryland | 21231 | — |
| Maryland Oncology Hematology, PA | Columbia | Maryland | 21044 | — |
| Alliance Hematology Oncology, PA - Carroll County Cancer Center | Westminster | Maryland | 21157 | — |
| Minnesota Oncology Hematology, PA | Minneapolis | Minnesota | 55404 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| St. Joseph Oncology, Inc. | Saint Joseph | Missouri | 64507 | — |
| Hematology/Oncology Consultants | St Louis | Missouri | 63136 | — |
| Arch Medical Services - Center for Cancer Care & Research | St Louis | Missouri | 63141 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89109 | — |
| New York Oncology Hematology, PC | Albany | New York | 12208 | — |
| SUNY Upstate Medical University - Regional Oncology Center | Syracuse | New York | 13210 | — |
| Northwestern Carolina Oncology & Hematology | Hickory | North Carolina | 28602 | — |
| Cancer Centers of North Carolina | Raleigh | North Carolina | 27607 | — |
| Willamette Valley Cancer Center | Eugene | Oregon | 97401 | — |
| Northwest Cancer Specialists | Portland | Oregon | 97225 | — |
| Medical Oncology Associates | Kingston | Pennsylvania | 18704 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29605 | — |
| Texas Oncology Cancer Center | Austin | Texas | 78731 | — |
| Texas Cancer Center at Medical City | Dallas | Texas | 75230-2510 | — |
| Texas Oncology, PA | Dallas | Texas | 75231 | — |
| Texas Oncology - Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Oncology, PA | Fort Worth | Texas | 76104 | — |
| Alison Cancer Center | Midland | Texas | 79701 | — |
| West Texas Cancer Center | Odessa | Texas | 79761 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Texas Oncology Cancer Care & Research Center | Waco | Texas | 76712 | — |
| Texas Oncology, PA - Deke Slayton Cancer Center | Webster | Texas | 77598 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Oncology & Hematology Associates of SW Virginia, Inc. | Salem | Virginia | 24153 | — |
| Puget Sound Cancer Center | Seattle | Washington | 98133 | — |
| Northwest Cancer Specialists - Vancouver Cancer Center | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00319969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2009 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00319969 live on ClinicalTrials.gov.